Tennan competitive analysis

Explore patent oppositions filed by Tennan against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 25, 2026
Systems And Methods For Chromatography Use And RegenerationREGENERON PHARMACEUTICALSAug 18, 2026
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 28, 2026
Method And Apparatus Relating To Injection Molding Contact Lens Mold HalvesCOOPERVISIONJul 10, 2026
Leadless Pacing Device For His Bundle And Bundle Branch PacingMEDTRONICJun 3, 2026
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 3, 2026
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression Innpm1MEMORIAL SLOAN KETTERING CANCER CENTERApr 8, 2026
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIAJan 13, 2026
Chimeric Antigen Receptors Targeting B-Cell Maturation AntigenTHE UNITED STATES OF AMERICADec 31, 2025
Method And Compositions For Cellular ImmunotherapyFRED HUTCHINSON CANCER CENTEROct 8, 2025

Explore Tennan's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 12, 2025A Parcel Transport Container, Assembly And Monitoring System1
Nov 4, 2020Integral Vacuum Fan Housing1

Latest PTAB cases involving Tennan

Discover the latest PTAB cases involving Tennan, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 8, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Tennan

IPR2021-00602Mar 9, 2021TENNANTOXYGENATOR WATERInstitution Denied
IPR2021-00625Mar 9, 2021TENNANTOXYGENATOR WATERFinal Written Decision - Appealed

Peer Comparison New

IP litigation analysis comparing Tennan with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BOULT WADE TENNANT62 - - -
DANA FARBER CANCER INSTITUTE - 2531
REGENERON PHARMACEUTICALS55142932
SANOFI BIOTECHNOLOGY - 59 - -